GSK
889 hedge funds and large institutions have $11.1B invested in GSK in 2023 Q4 according to their latest regulatory filings, with 126 funds opening new positions, 269 increasing their positions, 343 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
889
Holders Change
+48
Holders Change %
+5.71%
% of All Funds
13.03%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.19%
New
126
Increased
269
Reduced
343
Closed
63
Calls
$227M
Puts
$104M
Net Calls
+$123M
Net Calls Change
-$164M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$634M |
| 2 |
Holocene Advisors
New York
|
$305M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
$92.3M |
| 4 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
$148M |
| 5 |
AC
Armistice Capital
New York
|
$81.4M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$316K |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
$179M |
| 3 |
Goldman Sachs
New York
|
$149M |
| 4 |
Millennium Management
New York
|
$53.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
$1.71M |
